Channel Therapeutics Corporation Common Stock (CHRO)
1.3600
-0.0100 (-0.73%)
NYSE · Last Trade: Apr 26th, 12:43 PM EDT
Detailed Quote
Previous Close | 1.370 |
---|---|
Open | 1.330 |
Bid | 1.280 |
Ask | 1.340 |
Day's Range | 1.260 - 1.360 |
52 Week Range | 0.4500 - 3.800 |
Volume | 68,644 |
Market Cap | 31.39B |
PE Ratio (TTM) | - |
EPS (TTM) | - |
Dividend & Yield | N/A (N/A) |
1 Month Average Volume | 1,870,863 |
Chart
News & Press Releases
Via Benzinga · April 17, 2025
Power Metallic Mines Inc. (TSX-V: PNPN) (OTCBB: PNPNF) (Frankfurt: IVV) has reported new drill results from its Winter 2025 campaign at the Tiger Zone, returning shallow polymetallic hits and confirming early signs of Lion-style, copper-dominant mineralization in this high-priority area.
Via AB Newswire · April 17, 2025
Under the agreement, Ligand’s wholly owned subsidiaries, Pelthos Therapeutics Inc. and LNHC, Inc. will combine with CHRO Merger Sub Inc., a wholly-owned subsidiary of Channel.
Via Stocktwits · April 17, 2025
Via Benzinga · April 17, 2025
Ligand and Channel Therapeutics to merge in $50 million deal to launch Zelsuvmi for molluscum and advance NaV 1.7 chronic pain programs.
Via Benzinga · April 17, 2025

Via Benzinga · January 23, 2025

Via Benzinga · November 26, 2024

Via Benzinga · October 18, 2024

Via Benzinga · October 18, 2024

Via Benzinga · October 16, 2024

Via Benzinga · October 4, 2024

Via Benzinga · October 4, 2024

Via Benzinga · October 1, 2024

Via Benzinga · September 26, 2024

Company Executives Share Vision and Answer Questions Live at VirtualInvestorConferences.com
By Virtual Investor Conferences · Via GlobeNewswire · September 16, 2024

Chromocell Therapeutics just reported results for the second quarter of 2024.
Via InvestorPlace · August 20, 2024

Via Benzinga · May 29, 2024

Chromocell Therapeutics just reported results for the first quarter of 2024.
Via InvestorPlace · May 20, 2024

Via Benzinga · April 19, 2024

Via Benzinga · April 19, 2024

Shares of The Travelers Companies, Inc. (NYSE: TRV) fell sharply during Wednesday’s session following first-quarter earnings.
Via Benzinga · April 17, 2024